Skip to main content

Find Clinical Trials

Home
Conditions
Iris Melanoma

Clinical trial condition

Iris Melanoma

Explore clinical trials studying Iris Melanoma. Study availability and eligibility vary by location and protocol.

13 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Iris Melanoma trial results

Completed

Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma

NCT00085189

Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, Extraocular Extension Melanoma, +31 more
Locations: University of Southern California Los Angeles, California, United States

View Trial Details

Completed

Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma

NCT00288041

Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Extraocular Extension Melanoma, Eye Diseases, +20 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Active, Not Recruiting

Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma

NCT02068586

Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, Eye Diseases, +23 more
Locations: Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details